Accelerate research, empower industry

shRNA Gene Knockdown

Overview

Hysigen provides an extensive array of shRNA reagents to furnish you with optimal tools for your RNAi experiments. We specialize in packaging all major virus types, including lentivirus, AAV, and adenovirus, across various titer scales, facilitating the delivery of your shRNAs into difficult-to-transfect cells.


Key Advancements

  • Abundant collections of vector backbones and components.

  • 100% sequence validation, ensuring accuracy, with rapid turnaround times and competitive pricing.

  • Robust technical support for shRNA selection, vector design, and troubleshooting, enhancing the efficiency of your experiments.


Workflow

1. Cell Preparation

Cell resuscitation culture, using cells with a fast proliferation rate, cells capable of forming good monoclonal clones, and cells with high transfection efficiency are the key factors for the success of the experiment, and it is recommended to meet the following conditions:

- Resuscitated cells should be passaged more than 3 times;

- Use cells with good clone formation as much as possible;

- Passaging of cells 2 days before transfection;

- Change the cell culture medium one day before transfection;

- Keep the cells at 50-85% confluence before transfection to maintain   the cells in the best proliferation state.


2. shRNA + SSR transfection (or Transduction, Depends on the vector type )

- Cell density is 70-85%.

- Mix shRNA plasmid+lipo and add to cells.

- After incubation at (37 ºC, 5% CO2) overnight.

- Observe the GFP expression rate in cell after 48 hours; the positive rate of the GFP control should be more than 50%.

Note: All the media used in the transfection process are antibiotic-free media; otherwise, it will lead to cell death.


3. Transfection and Drug Screening

After 48h of transfection, the cells are screened with Puromycin (Puro); Once cell confluence reaches 80%, passage the cells at a 1:2–1:3 ratio and continue drug screening for 1–2 weeks. This completes the construction of the stable transfected cell line.



Technical Information

RNA Interference (RNAi) is the process of effectively silencing or inhibiting the expression of a target gene, which is achieved by degrading the corresponding mRNA of the target gene using double-stranded RNA (dsRNA).

      未标题-2.jpg

Deliverables

Stable Cell Line Model

Approach

Cell Type

Price

Turnaround

Deliverables

shRNA (3+1) Knockdown : 3shRNA +1 control


Lentivirus (Pooled Cells)

Easy

$3,499

8-13 weeks

Pooled cells, each pooled cell with two vials of cells (>10^6 cells/vial)

Normal

$4,199

8-13 weeks

Difficult

$5,599

10-15 weeks

Lentivirus (Single Clone)

Easy

$4,199

13-18 weeks

Normal

$4,899

13-18 weeks

Difficult

$6,299

18-23 weeks

Example
Stable Knockdown of mAimp1 in RAW264.7 Cell line Using shRNA

• Utilized the VIRUS-Free™ PiggyBac system for stable genomic integration (Fig. 1).


• Designed three highly specific shRNAs targeting mAimp1 (Fig. 1) and screened for optimal efficacy.


• Knockdown efficiency in stable pool cells was validated via qPCR and Western Blot (Fig. 3).


Figure 1. Plasmid map

SH-case1.jpg



Figure 2. Schematic of the shRNA knockdown strategy

SH-case2.jpg



Figure 3. Validation of mAimp1 Knockdown: mRNA and Protein Analysis

SH-case3.jpg

Publications

微信图片_20250916135600_813_180.jpg

微信图片_20250916135600_813_180.jpg

微信图片_20250916135600_813_180.jpg

微信图片_20250916135600_813_180.jpg

微信图片_20250916135600_813_180.jpg

微信图片_20250916135600_813_180.jpg

微信图片_20250916135600_813_180.jpg

微信图片_20250916135600_813_180.jpg

8_看图王.web.png

IF: 45.5

Chen Y, Chen S, Liu Z, Wang Y, An N,

Chen Y, Peng Y, Liu Z, Liu Q, Hu X.

Red blood cells undergo lytic

programmed cell death involving

NLRP3. Cell. 2025 Apr 16:S0092-8674(25)00389-7.


IF: 39.3

Ma B, Ju A, Zhang S, et al.

Albumosomes formed by

cytoplasmic pre-folding

albumin maintain mitochondrial

homeostasis and inhibit nonalcoholic

fatty liver disease[J]. Signal

Transduction and Targeted Therapy,

2023, 8(1): 229.

IF: 26.6

Wu W, Pu Y, Gao S, et al. Bacterial

Metabolism-Initiated Nanocatalytic

Tumor Immunotherapy[J].

Nano-Micro Letters, 2022, 14(1):

1-21.

IF: 37.3

Zheng Z, Zeng X, Zhu Y, et al.

CircPPAP2B controls metastasis of

clear cell renal cell carcinoma via

HNRNPC-dependent alternative

splicing and targeting the miR-182-

5p/CYP1B1 axis[J]. Molecular Cancer,

2024, 23(1): 4.

IF: 18.9

Sun J, Yang F, Wang L, et al. Delivery

of coenzyme Q10 loaded micelle

targets mitochondrial ROS and

enhances efficiency of mesenchymal

stem cell therapy in intervertebral

disc degeneration[J]. Bioactive

Materials, 2023, 23: 247-260.

IF: 18.9

Wei X, Wang L, Duan C, et al. Cardiac

patches made of brown adipose-derived

stem cell sheets and conductive

electrospun nanofibers restore infarcted

heart for ischemic myocardial infarction[J]. Bioactive Materials, 2023, 27: 271-287.

IF: 16

Gao Y, Zhu Y, Wang H, et al.

Lipid-mediated phase separation of

AGO proteins on the ER controls

nascent-peptide ubiquitination[J].

Molecular Cell, 2022, 82(7):

1313-1328. e8.

IF: 15.1

Chen X, Hao Y, Liu Y, et al.

NAT10/ac4C/FOXP1 promotes

malignant progression and

facilitates immunosuppression by

reprogramming glycolytic

metabolism in cervical cancer[J].

Advanced Science, 2023, 10(32):

2302705.

IF: 12.8

Yang H H, Jiang H L, Tao J H, et al.

Mitochondrial citrate accumulation

drives alveolar epithelial cell

necroptosis in lipopolysaccharide

-induced acute lung injury[J].

Experimental & Molecular Medicine,

2022, 54(11): 2077-2091.

Contact us
Name
*
Country/Region
*
How would you like us to contact you?
*
E-mail
*
Institution
Phone
Subject
*
Verification code
 Change Image
*
Submit
Tell Us Your Demand
Contact Us


Address: 56 Sugar Creek Blvd Suite 375, Sugar Land, TX 77478

Email: info@hysigen.com

Telephone: 628-777-8169 (US)

Accelerate research, empower industry